Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10901 - 10925 of 12697 in total
Depatuxizumab has been used in trials studying the treatment and diagnostic of Adenocarcinoma and Advanced Solid Tumors.
Investigational
Matched Description: … Depatuxizumab has been used in trials studying the treatment and diagnostic of Adenocarcinoma and Advanced …
CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Description: … CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific …
Pegadricase is under investigation in clinical trial NCT01021241 (Safety and Efficacy Study of Intravenous Uricase-PEG 20).
Investigational
Matched Description: … Pegadricase is under investigation in clinical trial NCT01021241 (Safety and Efficacy Study of Intravenous …
Epigallo Catechin Gallate is under investigation in clinical trial NCT00799890 (Sunphenon in Progressive Forms of Multiple Sclerosis).
Investigational
Matched Description: … Catechin Gallate is under investigation in clinical trial NCT00799890 (Sunphenon in Progressive Forms of
Osalmid is under investigation in clinical trial NCT03670173 (Safety and Efficacy Assessments of Osalmid in Multiple Myeloma).
Investigational
Matched Description: … Osalmid is under investigation in clinical trial NCT03670173 (Safety and Efficacy Assessments of Osalmid …
Pexmetinib is under investigation in clinical trial NCT04074967 (Study of ARRY-614 Plus Either Nivolumab or Ipilimumab).
Investigational
Matched Description: … Pexmetinib is under investigation in clinical trial NCT04074967 (Study of ARRY-614 Plus Either Nivolumab …
BP-14979 is under investigation in clinical trial NCT01785147 (Efficacy and Safety of BP1.4979 in Smoking Cessation).
Investigational
Matched Description: … BP-14979 is under investigation in clinical trial NCT01785147 (Efficacy and Safety of BP1.4979 in Smoking …
tgAAG-76 consists of a recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing RPE65.
Investigational
Matched Description: … tgAAG-76 consists of a recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing …
XEN-D0501 is a tetrahydronaphthyl urea-based selective TRPV1 antagonist being investigated for the treatment of erythromelalgia.
Investigational
Matched Description: … is a tetrahydronaphthyl urea-based selective TRPV1 antagonist being investigated for the treatment of
Propafenone, (r)- is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).
Investigational
Matched Description: … Propafenone, (r)- is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone …
EHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.
Investigational
Matched Description: … It is a broad spectrum of specific HCV proteins. …
Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.
Investigational
Matched Description: … Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow …
Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome.
Investigational
Matched Description: … Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome. …
Ecromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.
Investigational
Matched Description: … Ecromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma …
Actinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive.
Investigational
Matched Description: … Actinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive …
Fiacitabine has been used in trials studying the treatment of HIV Infections and Cytomegalovirus Infections.
Investigational
Matched Description: … Fiacitabine has been used in trials studying the treatment of HIV Infections and Cytomegalovirus Infections …
Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis.
Investigational
Matched Description: … Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis …
PKI-179 has been used in trials studying the treatment of Advanced Malignant Solid Tumors.
Investigational
Matched Description: … PKI-179 has been used in trials studying the treatment of Advanced Malignant Solid Tumors. …
FLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.
Investigational
Matched Description: … FLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.[L9875] …
BI-765063 is a humanized IgG4 monoclonal antibody antagonist of signal regulatory protein α (SIRPα).
Investigational
Matched Description: … BI-765063 is a humanized IgG4 monoclonal antibody antagonist of signal regulatory protein α (SIRPα). …
NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).
Investigational
Matched Description: … NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF …
An IgG1 murine monoclonal anti-idiotype antibody (Ab2), ACA-125, was developed to bind to anti-CA 125 antibodies. ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas. This new concept of oncological immunotherapy consists of an attempt to trigger the immune system of the host...
Investigational
Matched Description: … This new concept of oncological immunotherapy consists of an attempt to trigger the immune system of ... Antiidiotypic antibodies bearing the internal image of an antigen expressed on the surface of the tumor ... ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas …
Ligelizumab is a humanized IgG1k monoclonal antibody targeted against immunoglobulin E (IgE). Similar in mechanism to omalizumab, another IgE-directed monoclonal antibody, ligelizumab has a distinct binding epitope as compared to its peer (with a small degree of overlap) which appears to confer a greater affinity for free serum IgE and...
Investigational
Matched Description: … Initial trials of ligelizumab suggest a greater efficacy over its predecessor for the treatment of CSU ... anti-IgE antibody therapy in the treatment of CSU has been previously established with omalizumab. ... While the precise pathogenesis of CSU is not entirely clear, autoantibodies against IgE receptors, and …
SOT-107 is a drug that is a combination of a protein called transferrin and a poison called diphtheria toxin. This drug treat for a type of brain cancer called a high grade glioma brain tumour. About half of all brain tumours are gliomas.
Investigational
Matched Description: … About half of all brain tumours are gliomas. ... This drug treat for a type of brain cancer called a high grade glioma brain tumour. ... SOT-107 is a drug that is a combination of a protein called transferrin and a poison called diphtheria …
VX-148 is a second-generation, orally administered inhibitor of inosine monophosphate dehydrogenase (IMPDH). The IMPDH enzyme plays a key role in regulating immune response and proliferation of specific cell types, including lymphocytes. VX-148 is a developed for the treatment of autoimmune diseases.
Investigational
Matched Description: … VX-148 is a developed for the treatment of autoimmune diseases. ... VX-148 is a second-generation, orally administered inhibitor of inosine monophosphate dehydrogenase ( ... The IMPDH enzyme plays a key role in regulating immune response and proliferation of specific cell types …
Displaying drugs 10901 - 10925 of 12697 in total